Department of Nutrition and Food Hygiene, School of Public Health, Peking University, Beijing 100191, China.
Medical Center, SinoMed Peptide Valley Bioengineering Co., Ltd., Beijing 100027, China.
Mar Drugs. 2018 Jan 8;16(1):16. doi: 10.3390/md16010016.
Impaired wound healing is a major clinical problem in patients with diabetes and is the leading cause of lower limb amputation. This study is aimed to observe the effects of small molecule oligopeptides isolated from sea cucumber (SCCOPs) on the wound healing process in diabetic mice. Ninety db/db male mice were divided into five groups, including the model control group, whey protein group (0.50 g/kg) and three SCCOPs dose groups (0.25 g/kg, 0.50 g/kg and 1.00 g/kg). Additionally, 18 db/m male mice were used as normal control group. After full-thickness incisions on the dorsum, mice in SCCOPs-treated groups were intragastrically administered SCCOPs, while others were administered vehicle or whey protein. Mice were sacrificed on days 4, 7 and 14. The wound healing condition, inflammatory response, angiogenesis, collagen deposition, oxidative stress and nutritional status were evaluated. A pathological report showed increased vascularisation, collagen deposition and epithelialisation in SCCOPs-treated groups. SCCOPs-treated mice showed decreased C-reactive protein (CRP), interleukin (IL)-6, IL-8, tumor necrosis factor (TNF)-α, chemokine (C-C motif) ligand 2 (CCL2) and reactive oxygen species (ROS) contents, and increased IL-10, stromal cell-derived factor-1 alpha (SDF-1α), nitric oxide (NO), albumin (ALB), prealbumin (PA) and transferrin (TRF) levels and vascular endothelial growth factor (VEGF) expression. All parameters were significant ( < 0.05) in comparison to model control group. These results suggest that treatment with SCCOPs can promote significant wound healing in diabetic mice.
创面愈合受损是糖尿病患者的一个主要临床问题,也是导致下肢截肢的主要原因。本研究旨在观察海参小分子寡肽(SCCOPs)对糖尿病小鼠创面愈合过程的影响。90 只 db/db 雄性小鼠分为 5 组,包括模型对照组、乳清蛋白组(0.50 g/kg)和 3 个 SCCOPs 剂量组(0.25 g/kg、0.50 g/kg 和 1.00 g/kg)。此外,还使用 18 只 db/m 雄性小鼠作为正常对照组。在背部全层切开后,SCCOPs 治疗组小鼠灌胃给予 SCCOPs,其他组小鼠给予载体或乳清蛋白。在第 4、7 和 14 天处死小鼠。评估创面愈合情况、炎症反应、血管生成、胶原沉积、氧化应激和营养状况。病理报告显示,SCCOPs 治疗组血管生成、胶原沉积和上皮化增加。SCCOPs 治疗组小鼠的 C 反应蛋白(CRP)、白细胞介素(IL)-6、IL-8、肿瘤坏死因子(TNF)-α、趋化因子(C-C 基序)配体 2(CCL2)和活性氧(ROS)含量降低,IL-10、基质细胞衍生因子-1 阿尔法(SDF-1α)、一氧化氮(NO)、白蛋白(ALB)、前白蛋白(PA)和转铁蛋白(TRF)水平以及血管内皮生长因子(VEGF)表达增加。与模型对照组相比,所有参数均有显著差异(<0.05)。这些结果表明,SCCOPs 治疗可促进糖尿病小鼠创面愈合。